Forum

In spite of not being a rare disease, being classified as a disease by the WHO (World Health Organization) and being one of the most psychologically devastating chronic skin diseases, with a major impact on both patients and their families, vitiligo is still today underrated and underestimated. There are still many dermatologists who minimize the impact of the disease and trivialize the condition or deceive patients' expectations, leaving them vulnerable to therapies not proven effective often found within the depths of Internet. In view of the fact that these last ten years have witnessed a growing interest for research and an improved understanding of the mechanisms regulating the disease, its genetic susceptibility and the role played by autoimmunity this highly intense conference, the Faculty of which is made up by the most eminent experts in the field, sets the goal of becoming an ideal occasion for an innovative and in-depth analysis of vitiligo. " The scientific sessions of the Congress are not opened to patients, however a special day has been set aside specifically for patients. See Below: September 25 will be dedicated to patients: "Vitiligo, where are we now? This day will provide interaction between patients, clinicians and scientists. The goal of this event is to allow patients to play an active role in the field of research and to provide them with more information on existing therapies. Patients will have the chance to work in partnership with investigators, clinicians and healthcare professionals, interacting with members of the international vitiligo scientific community. Participation is free of charge. To learn more details, please visit the congress website at www.vwc2010.com